The Patent Finder

Maintenance fees coming due

Adneuris Therapeutics, Inc.

5 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Dec 18, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 10,323,040Process for the Preparation of 5-Fluorotryptophol
In force
Fee due Dec 18, 2026
Lapses if unpaid Jun 21, 2027
 · High confidence
Adneuris Therapeutics, Inc.In forceDec 18, 2026Jun 21, 2027High confidence
US 9,289,416Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
In force
Fee due Sep 22, 2027
Lapses if unpaid Mar 22, 2028
 · High confidence
Adneuris Therapeutics, Inc.In forceSep 22, 2027Mar 22, 2028High confidence
US 9,308,196Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
In force
Fee due Oct 12, 2027
Lapses if unpaid Apr 12, 2028
 · High confidence
Adneuris Therapeutics, Inc.In forceOct 12, 2027Apr 12, 2028High confidence
US 9,320,725Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-DIMETHYL-4-Phenyl-4'9'-Dihydro-3'H-SPIRO[CYCLOHEXANE-1,1'-Pyrano[3,4,B]INDOL]-4-Amine and a Gabapentinoid
In force
Fee due Oct 26, 2027
Lapses if unpaid Apr 26, 2028
 · High confidence
Adneuris Therapeutics, Inc.In forceOct 26, 2027Apr 26, 2028High confidence
US 9,320,729Pharmaceutical Composition Comprising (1r,4r)-6'-flouro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
In force
Fee due Oct 26, 2027
Lapses if unpaid Apr 26, 2028
 · High confidence
Adneuris Therapeutics, Inc.In forceOct 26, 2027Apr 26, 2028High confidence
5 of 5 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited